Literature DB >> 14580805

Clinico-haematological and mineral studies on experimental maduramicin toxicity in chickens.

Tersem Singh1, R P Gupta.   

Abstract

Clinico-haematological and mineral studies were carried out in experimental chickens given maduramicin medicated feed at 5 and 10 ppm for 21 days. Maduramicin medication in both medicated groups caused growth retardation. Clinical signs namely watery diarrhoea, depression, dullness and ruffled feathers were noticed in chickens from second week of the medication at 10 ppm but this effect was seen from third week in the birds given maduramicin at 5 ppm. Maduramicin medication caused significant reduction in haemoglobin in both the medicated group from day 14 and total erythrocyte count and packed cell volume in 10 ppm group on day 21. There was an increase in MCV in 10 ppm group on day 21 indicating macrocytic anaemia and decrease in mean corpuscular haemoglobin concentration (MCHC) in both the medicated groups indicating hypochromic anaemia. The leucopenia due to lymphopenia was observed in 10 ppm group on day 21. Maduramicin medication caused significant increase in serum Zn in 10 ppm group and decrease in Cu concentration in both the medicated groups from day 14. It is concluded that maduramicin caused toxic effects from day 14 in both the medicated groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580805     DOI: 10.1016/j.vetpar.2003.07.009

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  8 in total

1.  Maduramicin induces cardiac muscle cell death by the ROS-dependent PTEN/Akt-Erk1/2 signaling pathway.

Authors:  Xin Chen; Yue Li; Meng Feng; Xiaoyu Hu; Hai Zhang; Ruijie Zhang; Xiaoqing Dong; Chunxiao Liu; Zhao Zhang; Shanxiang Jiang; Shile Huang; Long Chen
Journal:  J Cell Physiol       Date:  2018-12-03       Impact factor: 6.384

2.  Genomics-driven discovery of the biosynthetic gene cluster of maduramicin and its overproduction in Actinomadura sp. J1-007.

Authors:  Ran Liu; Fang Fang; Ziheng An; Renqiong Huang; Yong Wang; Xiao Sun; Shuai Fu; Aisi Fu; Zixin Deng; Tiangang Liu
Journal:  J Ind Microbiol Biotechnol       Date:  2019-12-18       Impact factor: 3.346

3.  Maduramicin induces apoptosis and necrosis, and blocks autophagic flux in myocardial H9c2 cells.

Authors:  Xin Chen; Long Chen; Shanxiang Jiang; Shile Huang
Journal:  J Appl Toxicol       Date:  2017-10-19       Impact factor: 3.446

4.  Anticoccidial activity of the methanolic extract of Musa paradisiaca root in chickens.

Authors:  George Nnamdi Anosa; O Josephine Okoro
Journal:  Trop Anim Health Prod       Date:  2010-08-19       Impact factor: 1.559

5.  Maduramicin inactivation of Akt impairs autophagic flux leading to accumulated autophagosomes-dependent apoptosis in skeletal myoblast cells.

Authors:  Xiaoqing Dong; Rui Zhao; Yue Li; Qianyun Yu; Xin Chen; Xiaoyu Hu; Jing Ma; Xiaoling Chen; Shile Huang; Long Chen
Journal:  Int J Biochem Cell Biol       Date:  2019-07-17       Impact factor: 5.652

6.  Maduramicin induces apoptosis through ROS-PP5-JNK pathway in skeletal myoblast cells and muscle tissue.

Authors:  Xin Chen; Yumei Zhang; Shanxiang Jiang; Shile Huang
Journal:  Toxicology       Date:  2019-06-20       Impact factor: 4.571

7.  Maduramicin arrests myocardial cells at G0/G1 phase of the cell cycle through inhibiting AKT-Cyclin D1 signaling.

Authors:  Xin Chen; Chang Liu; Meng Zhang; Yumei Zhang
Journal:  3 Biotech       Date:  2021-06-20       Impact factor: 2.893

8.  Maduramicin inhibits proliferation and induces apoptosis in myoblast cells.

Authors:  Xin Chen; Ying Gu; Karnika Singh; Chaowei Shang; Mansoureh Barzegar; Shanxiang Jiang; Shile Huang
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.